COVID IGG ANTIBODY(CLIA)

This test is a blood test that detects IgG antibodies produced in response to SARS-CoV-2 infection using the Chemiluminescent Immunoassay (CLIA) method. IgG antibodies typically develop after infection or vaccination and indicate past exposure.

The purpose of this test is to:

• Detect IgG antibodies against COVID-19
• Identify past infection or exposure
• Assess immune response after infection or vaccination
• Provide more accurate results using the CLIA method
• Support clinical and epidemiological evaluation

COVID IGG ANTIBODY(CLIA) Test Purpose

The COVID-19 IgG Antibody Test (CLIA) is a blood test that detects Immunoglobulin G (IgG) antibodies produced by the immune system in response to infection with SARS-CoV-2, the virus that causes COVID-19. Using Chemiluminescent Immunoassay (CLIA) technology, this test offers high sensitivity and specificity for detecting IgG antibodies, making it a reliable method for evaluating an individual’s immune response following COVID-19 infection or vaccination.

This test is primarily used to determine whether a person has developed IgG antibodies after recovering from COVID-19 or following vaccination. It helps assess previous exposure to the virus and can support clinical evaluation in individuals who had symptoms consistent with COVID-19 but were not tested during the active phase of the illness. Healthcare providers may also recommend the test to monitor antibody response in certain clinical situations or research settings.

It is important to note that the COVID-19 IgG Antibody Test (CLIA) is not intended to diagnose an active COVID-19 infection, as antibodies typically develop several days to weeks after infection. If an active infection is suspected, RT-PCR or approved rapid antigen testing is more appropriate. The results should always be interpreted along with clinical history, vaccination status, symptoms, and other laboratory findings for an accurate assessment.

COVID IGG ANTIBODY(CLIA) Test is Recommended for Individuals:

• Individuals who want to know if they have previously been infected with COVID-19.
• People who have recovered from COVID-19 and wish to assess their IgG antibody response.
• Individuals who want to evaluate antibody development after COVID-19 vaccination, when advised by a healthcare provider.
• People with a history of COVID-19 symptoms who were not tested during the active infection.
• Healthcare workers and individuals at increased risk of COVID-19 exposure. Anyone advised by a physician to assess previous SARS-CoV-2 exposure or immune response.

FAQs

1. What does the COVID-19 IgG Antibody (CLIA) Test detect?
The test detects IgG antibodies produced by the immune system after COVID-19 infection or vaccination. It helps identify whether your body has developed an immune response to SARS-CoV-2.

2. Can this test diagnose an active COVID-19 infection?
No. The COVID-19 IgG Antibody (CLIA) Test is not used to diagnose an active infection. RT-PCR or rapid antigen tests are recommended for detecting current COVID-19 infection.

3. Do I need to fast before the COVID-19 IgG Antibody (CLIA) Test?
No. Fasting is generally not required before this blood test. However, always follow any specific instructions provided by your healthcare provider or diagnostic laboratory.